Close Menu

NEW YORK (GenomeWeb) — Strata Oncology said today that it will help identify patients for  the National Cancer Institute's Molecular Analysis for Therapy Choice (NCI-MATCH) precision medicine trial.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.